Drug Topics Community Pharmacists' Report

June 03, 2012

Web Version  |  Manage Your Profile  |  Digital Edition  |  Share with a colleague

Facebook Like   Twitter Tweet

DT Blog

State Boards of Pharmacy – watchdogs or lapdogs?

When most of our pharmacy practice acts were first promulgated, our profession consisted mainly of independently operated community pharmacies, and the pharmacists who ran them volunteered to operate the state Boards of Pharmacy. How things have changed! » More

Continuing Education

Psychopharmacology for the elderly

Late-life depression can occur in up to 50% of patients. Pharmacists can screen for unidentified cases and advocate for routine measurement of symptom severity.

To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.

TODAY'S HEADLINES

McKesson's medication adherence network

At their recent ideaShare event, McKesson highlighted its Sponsored Clinical Services Network for hundreds of independent retail pharmacy owners and community pharmacists who are focused on increasing their role in healthcare delivery, improving patient outcomes, and finding new reimbursement avenues, the company said in a release. » More

FDA approves mirabegron for overactive bladder

FDA has approved mirabegron (Myrbetriq, Astellas Pharma US, Inc.) to treat adults with overactive bladder, a condition in which the bladder muscle cannot be controlled, squeezes too often, or squeezes without warning. » More

FDA approves generic version of acne treatment

FDA has approved Perrigo Company's abbreviated new drug application for a generic version of clindamycin phosphate and benzoyl peroxide 1.2%/5% gel (Duac Gel, Stiefel Laboratories), the company recently announced in a statement. The gel is indicated for the topical treatment of inflammatory acne vulgaris. » More

TAKE OUR SURVEY

Do you believe that the U.S. Supreme Court's ruling on the Affordable Care Act will bring about positive reform changes for patients and pharmacists?

a) Yes
b) No

Respond here and see what your colleagues think, too.

Want to see the results of our last survey which asked whether you supported the repeal of the ACA? Click here.

 

Subscribe Now!

You must click here to continue receiving the Drug Topics Community Pharmacists' Report

Check these out, too

FDA approves weight-loss treatment

Apixaban and stroke indication

Pharmacy school receives large grant

Nicotine patch safe after heart attack

Voices

DT Blog

JP at Large: This is pharmacy?

View from the Zoo: The vertebral solution

Viewpoints: Guest columnists' commentary

Regulatory and Legal: News, features, analysis

Meetings and Events

 
Powered by Modern Medicine Advanstar Medical Communications Group